Concepedia

Lloyd R. Kelland

LR

10

Publications

982

Citations

10

H-Index

1991

Active since

Affiliations

Institute of Cancer Research(Current)

Lloyd R. Kelland is an author at Institute of Cancer Research specializing in medicine, cancer therapeutics, and pharmacology.

Top concepts

MedicineOncologyPharmacologyTumor BiologyCancer TherapyOvarian CancerCell BiologyPathologyRadiation OncologyCancer Biology

Publications per year

1991–1998

10

Publications

10

Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug.

Lloyd R. Kelland, G Abel, Mark J. McKeage et al. · PubMed · 1993 · 224 citations

Chemoprevention Strategy, Active Platinum Drug, Pathology +18

Ammine/amine platinum(IV) dicarboxylates: a novel class of platinum complex exhibiting selective cytotoxicity to intrinsically cisplatin-resistant human ovarian carcinoma cell lines.

Lloyd R. Kelland, Barry A. Murrer, G Abel et al. · PubMed · 1992 · 168 citations

Chemoprevention Strategy, Cisplatin-resistant Cell Lines, Selective Cytotoxicity +16

Comparative in vitro cytotoxicity of taxol and Taxotere against cisplatin-sensitive and-resistant human ovarian carcinoma cell lines

Lloyd R. Kelland, G Abel · Cancer Chemotherapy and Pharmacology · 1992 · 138 citations

Oncogenic Agent, Medicine, Pharmacology +7

Mechanism-related circumvention of acquired cis-diamminedichloroplatinum(II) resistance using two pairs of human ovarian carcinoma cell lines by ammine/amine platinum(IV) dicarboxylates.

Lloyd R. Kelland, Prakash Mistry, G Abel et al. · PubMed · 1992 · 124 citations

Ammine/amine Platinum, Cisplatin Resistance, Oncology +14

Establishment and characterization of an in vitro model of acquired resistance to cisplatin in a human testicular nonseminomatous germ cell line.

Lloyd R. Kelland, Prakash Mistry, G Abel et al. · PubMed · 1992 · 94 citations

Metronomic Chemotherapy, Reproductive Biology, Tumor Biology +18

Rows per page

1–5 of 10